{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:39:04Z","timestamp":1794541144224,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":19,"publisher":"Springer New York","isbn-type":[{"value":"9781493968671","type":"print"},{"value":"9781493968695","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-6869-5_1","type":"book-chapter","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T09:58:42Z","timestamp":1491213522000},"page":"3-13","source":"Crossref","is-referenced-by-count":13,"title":["Development of Novel Vaccines Against Infectious Diseases Based on Chimpanzee Adenoviral Vector"],"prefix":"10.1007","author":[{"given":"Chao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudan","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,4]]},"reference":[{"issue":"3","key":"1_CR1","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3181\/00379727-84-20714","volume":"84","author":"WP Rowe","year":"1953","unstructured":"Rowe WP, Huebner RJ, Gilmore LK et al (1953) Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 84(3):570\u2013573","journal-title":"Proc Soc Exp Biol Med"},{"issue":"2","key":"1_CR2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/1566523013348689","volume":"1","author":"B Breyer","year":"2001","unstructured":"Breyer B, Jiang W, Cheng H et al (2001) Adenoviral vector-mediated gene transfer for human gene therapy. Curr Gene Ther 1(2):149\u2013162","journal-title":"Curr Gene Ther"},{"issue":"11","key":"1_CR3","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.3390\/v7112923","volume":"7","author":"H Uusi-Kerttula","year":"2015","unstructured":"Uusi-Kerttula H, Hulin-Curtis S, Davies J et al (2015) Oncolytic adenovirus: strategies and insights for vector design and immuno-oncolytic applications. Viruses 7(11):6009\u20136042. doi: 10.3390\/v7112923","journal-title":"Viruses"},{"issue":"5004","key":"1_CR4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1126\/science.2017680","volume":"252","author":"MA Rosenfeld","year":"1991","unstructured":"Rosenfeld MA, Siegfried W, Yoshimura K et al (1991) Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252(5004):431\u2013434","journal-title":"Science"},{"issue":"3","key":"1_CR5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1566523023347823","volume":"2","author":"V Legrand","year":"2002","unstructured":"Legrand V, Leissner P, Winter A et al (2002) Transductional targeting with recombinant adenovirus vectors. Curr Gene Ther 2(3):323\u2013339","journal-title":"Curr Gene Ther"},{"issue":"5","key":"1_CR6","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.addr.2004.12.010","volume":"57","author":"ZL Xu","year":"2005","unstructured":"Xu ZL, Mizuguchi H, Sakurai F et al (2005) Approaches to improving the kinetics of adenovirus-delivered genes and gene products. Adv Drug Deliv Rev 57(5):781\u2013802. doi: 10.1016\/j.addr.2004.12.010","journal-title":"Adv Drug Deliv Rev"},{"key":"1_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-3-642-00477-3_5","volume":"197","author":"R Heilbronn","year":"2010","unstructured":"Heilbronn R, Weger S (2010) Viral vectors for gene transfer: current status of gene therapeutics. Handb Exp Pharmacol 197:143\u2013170. doi: 10.1007\/978-3-642-00477-3_5","journal-title":"Handb Exp Pharmacol"},{"issue":"6","key":"1_CR8","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1128\/JVI.76.6.2667-2675.2002","volume":"76","author":"Z Xiang","year":"2002","unstructured":"Xiang Z, Gao G, Reyes-Sandoval A et al (2002) Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product. J Virol 76(6):2667\u20132675","journal-title":"J Virol"},{"issue":"5","key":"1_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2014.30","volume":"3","author":"X Wang","year":"2014","unstructured":"Wang X, Xing M, Zhang C et al (2014) Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China. Emerg Microbes Infect 3(5):e30. doi: 10.1038\/emi.2014.30","journal-title":"Emerg Microbes Infect"},{"issue":"12","key":"1_CR10","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1084\/jem.20081786","volume":"205","author":"M Perreau","year":"2008","unstructured":"Perreau M, Pantaleo G, Kremer EJ (2008) Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells. J Exp Med 205(12):2717\u20132725. doi: 10.1084\/jem.20081786","journal-title":"J Exp Med"},{"issue":"4","key":"1_CR11","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/jcb.22328","volume":"108","author":"AK Zaiss","year":"2009","unstructured":"Zaiss AK, Machado HB, Herschman HR (2009) The influence of innate and pre-existing immunity on adenovirus therapy. J Cell Biochem 108(4):778\u2013790. doi: 10.1002\/jcb.22328","journal-title":"J Cell Biochem"},{"issue":"8","key":"1_CR12","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/mt.2009.130","volume":"17","author":"MO Lasaro","year":"2009","unstructured":"Lasaro MO, Ertl HCJ (2009) New insights on adenovirus as vaccine vectors. Mol Ther 17(8):1333\u20131339. doi: 10.1038\/mt.2009.130","journal-title":"Mol Ther"},{"issue":"9","key":"1_CR13","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.vaccine.2008.12.051","volume":"27","author":"D Peruzzi","year":"2009","unstructured":"Peruzzi D, Dharmapuri S, Cirillo A et al (2009) A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines. Vaccine 27(9):1293\u20131300. doi: 10.1016\/j.vaccine.2008.12.051","journal-title":"Vaccine"},{"issue":"2","key":"1_CR14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/S0042-6822(03)00161-2","volume":"311","author":"PS Reddy","year":"2003","unstructured":"Reddy PS, Ganesh S, Limbach MP et al (2003) Development of adenovirus serotype 35 as a gene transfer vector. Virology 311(2):384\u2013393. doi: 10.1016\/S0042-6822(03)00161-2","journal-title":"Virology"},{"issue":"51","key":"1_CR15","doi-asserted-by":"publisher","first-page":"7344","DOI":"10.1016\/j.vaccine.2015.10.023","volume":"33","author":"C Cheng","year":"2015","unstructured":"Cheng C, Wang LS, Ko SY et al (2015) Combination recombinant simian or chimpanzee adenoviral vectors for vaccine development. Vaccine 33(51):7344\u20137351. doi: 10.1016\/j.vaccine.2015.10.023","journal-title":"Vaccine"},{"issue":"8","key":"1_CR16","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.1128\/Jvi.79.8.5090-5104.2005","volume":"79","author":"D Stone","year":"2005","unstructured":"Stone D, Ni SH, Li ZY et al (2005) Development and assessment of human adenovirus type 11 as a gene transfer vector. J Virol 79(8):5090\u20135104. doi: 10.1128\/Jvi.79.8.5090-5104.2005","journal-title":"J Virol"},{"issue":"11","key":"1_CR17","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/nprot.2010.134","volume":"5","author":"DM Zhou","year":"2010","unstructured":"Zhou DM, Zhou XY, Bian A et al (2010) An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector. Nat Protoc 5(11):1775\u20131785. doi: 10.1038\/nprot.2010.134","journal-title":"Nat Protoc"},{"issue":"2","key":"1_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/bit.21757","volume":"100","author":"MJE Havenga","year":"2008","unstructured":"Havenga MJE, Holterman L, Melis I et al (2008) Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: high yield and preserved bioactivity. Biotechnol Bioeng 100(2):273\u2013283. doi: 10.1002\/bit.21757","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"1_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2149\/tmh.2014-35","volume":"43","author":"KA Nguyen","year":"2015","unstructured":"Nguyen KA, Nguyen TT, Nguyen DV et al (2015) Evaluation of rapid neutralizing antibody detection test against rabies virus in human sera. Trop Med Health 43(2):111\u2013116. doi: 10.2149\/tmh.2014-35","journal-title":"Trop Med Health"}],"container-title":["Methods in Molecular Biology","Recombinant Virus Vaccines"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-6869-5_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T10:05:39Z","timestamp":1498385139000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-6869-5_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9781493968671","9781493968695"],"references-count":19,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-6869-5_1","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-6869-5","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}